This division supports the development and demonstration of modular platform technologies (without preference for any disease or application) that manipulate and interface with biology to enable new paradigms of clinical intervention for human health.
Division of Discovery Science & Technology (Bioengineering)
Grantee News ·A team of researchers has developed a noninvasive diagnostic method that may one day replace the biopsy with a simple blood test.
Grantee News ·An engineer is reporting fast screening of the surface proteins of exosomes for cancer diagnostics and biomarker discovery.
Grantee News ·With a new $1.3 million grant from the NIBIB, researchers led by University of Florida associate professor Zhoumeng Lin are building a tool that can offer drug researchers insight into how well a new nanoparticle-based cancer therapy will work, even before a drug enters animal testing. Source: Nano Magazine.
NIBIB in the News ·National Institutes of Health Common Fund’s Bridge2AI Program Will Build Ethical, Inclusive, and Interpretable Data Sets.
Grantee News ·Engineers developed a way to grow tiny replicas of the pancreas, using either healthy or cancerous pancreatic cells. Their models could help researchers develop and test potential drugs for pancreatic cancer.